If you look at page 30 of the Q, it shows that the exercise prices of the warrants were restated due to the PIPE accounting change. The new prices are actually .196 and .281 per share.
So it would seem that those are hanging over our heads in the short term anywhere above that range. Those warrants may have been part of the halt at .50, but it wasn't because we hit the strike price. I would guess that was part of the issue in the upper teens as well.
Doc, or anyone else, do we have any updated OS info?
Generex Biotechnology Corp. (GNBT) Stock Research Links